Cargando…
Is Pulse Pressure a Predictor of New-Onset Diabetes in High-Risk Hypertensive Patients?: A subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial
OBJECTIVE: Hypertensive patients have an increased risk of developing diabetes. Accumulating evidence suggests a close relation between metabolic disturbance and increased arterial stiffness. Here, we examined the association between pulse pressure and the risk of new-onset diabetes in high-risk Jap...
Autores principales: | Yasuno, Shinji, Ueshima, Kenji, Oba, Koji, Fujimoto, Akira, Hirata, Masakazu, Ogihara, Toshio, Saruta, Takao, Nakao, Kazuwa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858188/ https://www.ncbi.nlm.nih.gov/pubmed/20185746 http://dx.doi.org/10.2337/dc09-1447 |
Ejemplares similares
-
Physicians’ Attitudes towards and Reasons for Participation in the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial
por: Rahman, Mahbubur, et al.
Publicado: (2005) -
The association between uric acid levels and renal function of CKD patients with hyperlipidemia: a sub-analysis of the ASUCA trial
por: Kuwabara, Yoshihiro, et al.
Publicado: (2019) -
Intra-abdominal fat area is a predictor for new onset of individual components of metabolic syndrome: MEtabolic syndRome and abdominaL ObesiTy (MERLOT study)
por: NAKAO, Yoko M., et al.
Publicado: (2012) -
Effectiveness of nationwide screening and lifestyle intervention for abdominal obesity and cardiometabolic risks in Japan: The metabolic syndrome and comprehensive lifestyle intervention study on nationwide database in Japan (MetS ACTION-J study)
por: Nakao, Yoko M., et al.
Publicado: (2018) -
Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial
por: Kimura, Genjiro, et al.
Publicado: (2016)